
Antimicrobial resistance (AMR) is accelerating worldwide, with MRSA, carbapenem-resistant Enterobacteriaceae, and drug-resistant gonorrhea threatening modern medicine. As antibiotic development lags, AI-driven discovery, soil-derived compounds like teixobactin, and phage therapy offer renewed hope.



